Q4 2023 Holdings
Filed 2024-02-12 | 44 holdings | $566.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(IVV) | CORE S&P500 ETF | 464287200 | $118.8M | 248,710 | 21.0% |
| Vanguard Index FDS(VOO) | S&P 500 ETF SHS | 922908363 | $118.4M | 271,010 | 20.9% |
| Vanguard Tax-Managed FDS(VEA) | VAN FTSE DEV MKT | 921943858 | $74.2M | 1,549,700 | 13.1% |
| Ishares TR(IEFA) | CORE MSCI EAFE | 46432F842 | $55.0M | 782,380 | 9.7% |
| Vanguard Intl Equity Index F(VWO) | FTSE EMR MKT ETF | 922042858 | $38.8M | 942,960 | 6.8% |
| Ishares Inc(IEMG) | CORE MSCI EMKT | 46434G103 | $33.4M | 660,700 | 5.9% |
| Ishares TR(ITOT) | CORE S&P TTL STK | 464287150 | $22.8M | 216,860 | 4.0% |
| Vanguard Index FDS(VTI) | TOTAL STK MKT | 922908769 | $22.8M | 96,060 | 4.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $7.8M | 191,855 | 1.4% |
| Aercap Holdings NV(AER) | SHS | N00985106 | $6.7M | 90,000 | 1.2% |
| PG&E Corp(PCG) | COM | 69331C108 | $4.7M | 260,000 | 0.8% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $4.4M | 90,805 | 0.8% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $4.0M | 175,000 | 0.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.0M | 100,209 | 0.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $3.9M | 350,000 | 0.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.8M | 10,000 | 0.7% |
| LAS Vegas Sands Corp(LVS) | COM | 517834107 | $3.7M | 75,000 | 0.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $3.2M | 3,459,854 | 0.6% |
| Ambrx Biopharma Inc | COM | 641871108 | $3.0M | 207,500 | 0.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.9M | 70,000 | 0.5% |
| Springworks Therapeutics Inc | COM | 85205L107 | $2.7M | 73,949 | 0.5% |
| Permian Resources Corp(PR) | CLASS A COM | 71424F105 | $2.4M | 175,900 | 0.4% |
| Fluence Energy Inc(FLNC) | COM CL A | 34379V103 | $2.4M | 100,000 | 0.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $2.4M | 37,500 | 0.4% |
| Vesta Real Estate Corp(VTMX) | ADS | 92540K109 | $2.2M | 55,000 | 0.4% |
| Kinetik Holdings Inc(KNTK) | COM NEW CL A | 02215L209 | $2.2M | 64,900 | 0.4% |
| Klaviyo Inc(KVYO) | COM SER A | 49845K101 | $1.9M | 68,974 | 0.3% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $1.8M | 198,415 | 0.3% |
| HCI Group Inc(HCI) | COM | 40416E103 | $1.7M | 19,790 | 0.3% |
| Corebridge Finl Inc(CRBG) | COM | 21871X109 | $1.6M | 75,000 | 0.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $1.6M | 140,000 | 0.3% |
| Runway Growth Finance Corp(RWAY) | COM | 78163D100 | $1.2M | 91,739 | 0.2% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $964.1K | 74,792 | 0.2% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $957.0K | 50,000 | 0.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $780.0K | 500,000 | 0.1% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $713.0K | 100,000 | 0.1% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $696.6K | 33,997 | 0.1% |
| Bluebird BIO Inc | COM | 09609G100 | $690.0K | 500,000 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $521.7K | 103,300 | 0.1% |
| Molecular Templates Inc | COM NEW | 608550208 | $454.5K | 121,841 | 0.1% |
| Cidara Therapeutics Inc | COM | 171757107 | $293.1K | 369,099 | 0.1% |
| Vivid Seats Inc | COM CL A | 92854T100 | $189.6K | 30,000 | 0.0% |
| Purecycle Technologies Inc(PCT) | COM | 74623V103 | $47.6K | 11,754 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $34.9K | 132,435 | 0.0% |